SALIX PHARMACEUTICALS INC's ticker is SLXP and the CUSIP is 795435106. A total of 302 filers reported holding SALIX PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 0.88 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $2,812,000 | -15.7% | 18,000 | -6.7% | 0.11% | -58.0% |
| Q1 2015 | $3,335,000 | +40.4% | 19,300 | -6.6% | 0.26% | +58.6% |
| Q4 2014 | $2,376,000 | -15.5% | 20,670 | +14.8% | 0.16% | -24.3% |
| Q3 2014 | $2,812,000 | +31.0% | 18,000 | +3.4% | 0.21% | +32.9% |
| Q2 2014 | $2,146,000 | +19.0% | 17,400 | 0.0% | 0.16% | +15.0% |
| Q1 2014 | $1,803,000 | +18.6% | 17,400 | +3.0% | 0.14% | -9.7% |
| Q4 2013 | $1,520,000 | – | 16,900 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Verition Fund Management LLC | 2,787,800 | $481,760,000 | 55.98% |
| Brenner West Capital Advisors | 1,800,000 | $311,058,000 | 28.01% |
| FNY Managed Accounts LLC | 180,357 | $31,167,493,000 | 25.70% |
| Twin Securities, Inc. | 1,189,192 | $205,505,000 | 24.16% |
| FIRST NEW YORK SECURITIES LLC /NY | 98,099 | $16,952,488,000 | 16.70% |
| HARVEST MANAGEMENT LLC | 77,500 | $13,393,000 | 14.40% |
| Tyrus Capital S.A.M. | 687,800 | $118,859,000 | 13.24% |
| BARDIN HILL MANAGEMENT PARTNERS LP | 472,550 | $81,661,000 | 11.65% |
| ARGENTIERE CAPITAL AG | 151,500 | $26,181,000 | 10.81% |
| Sachem Head Capital | 725,000 | $125,425,000 | 8.31% |